A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design

BACKGROUND: No drug treatment to date has shown convincing clinical evidence of restoring cognitive function or preventing further decline after stroke. The ongoing ARTEMIDA study will evaluate the efficacy and safety of Actovegin for the symptomatic treatment of post-stroke cognitive impairment (PS...

Descripción completa

Detalles Bibliográficos
Autores principales: Guekht, Alla, Skoog, Ingmar, Korczyn, Amos D., Zakharov, Vladimir, Eeg, Martin, Vigonius, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919431/
https://www.ncbi.nlm.nih.gov/pubmed/24516413
http://dx.doi.org/10.1159/000357122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919431/
https://www.ncbi.nlm.nih.gov/pubmed/24516413
http://dx.doi.org/10.1159/000357122

Ejemplares similares